Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TARMICIndependent statistical analysis of Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TAS3351Independent statistical analysis of A Study of TAS3351 in NSCLC Patients With EGFRmt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05765734).
- TASCIndependent statistical analysis of Aortoiliac Stenosis in Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06020534).
- TASCIndependent statistical analysis of Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00524771).
- Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TASTERIndependent statistical analysis of Ticagrelor Administered as Standard Tablet or Orodispersible Formulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03822377).
- TAXYNERGYIndependent statistical analysis of Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC): primary endpoint results, effect estimate with…
- TAZPOWERIndependent statistical analysis of A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TBKT_HEPIndependent statistical analysis of Thera-Band® HEP for LBP Secondary Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02355275).
- TCM-700CIndependent statistical analysis of The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TCM-TMDIndependent statistical analysis of Traditional Chinese Medicine (TCM) for Temporomandibular Dysfunction (TMD): A Whole Systems Multi-site Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TD-0903 for ALI Associated With COVID-19: Complete Statistical AnalysisIndependent statistical analysis of TD-0903 for ALI Associated With COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04402866).
- Tdap Vaccine Safety for Plasma Donors: Complete Statistical AnalysisIndependent statistical analysis of Tdap Vaccine Safety for Plasma Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04142983).
- tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TDCS-FOGIndependent statistical analysis of Transcranial Direct Current Stimulation for Freezing of Gait: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02266004).
- TDCSSCHIZIndependent statistical analysis of Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TEAIndependent statistical analysis of Transcutaneous Electroacupuncture for Gastrointestinal Motility Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04349891).
- TEACOIndependent statistical analysis of TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00296816).
- TEAMIndependent statistical analysis of A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Team Science (The Liver Health Study): Complete Statistical AnalysisIndependent statistical analysis of Team Science (The Liver Health Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06924281).
- Team-Focused Implementation in Child Advocacy Centers: Complete Statistical AnalysisIndependent statistical analysis of Team-Focused Implementation in Child Advocacy Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05679154).
- TEAM2Independent statistical analysis of Reducing Stroke Risk in African-American Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04402125).
- TECH-EIndependent statistical analysis of Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Technology Enabled Services to Enhance Depression Care: Complete Statistical AnalysisIndependent statistical analysis of Technology Enabled Services to Enhance Depression Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05406791).
- Technology Enhanced Family Treatment: Complete Statistical AnalysisIndependent statistical analysis of Technology Enhanced Family Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03913013).
- Technology Interventions to Improve Outcomes After Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Technology Interventions to Improve Outcomes After Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04482400).
- Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03771274).
- TECTONICSIndependent statistical analysis of Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient: Complete Statistical AnalysisIndependent statistical analysis of Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04274686).
- Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C: Complete Statistical AnalysisIndependent statistical analysis of Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies: Complete Statistical AnalysisIndependent statistical analysis of Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142298).
- TELE001Independent statistical analysis of Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TeleBATRACIndependent statistical analysis of Translating Intensive Arm Rehabilitation in Stroke to a Telerehabilitation Format: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02665052).
- Telemedicine and Anger Management Groups With PTSD Veterans in the Hawaiian Islands: Complete Statistical AnalysisIndependent statistical analysis of Telemedicine and Anger Management Groups With PTSD Veterans in the Hawaiian Islands: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF): Complete Statistical AnalysisIndependent statistical analysis of Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03562247).
- Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas: Complete Statistical AnalysisIndependent statistical analysis of Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Telephone Tinnitus Education for Patients With Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Telephone Tinnitus Education for Patients With Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01129141).
- Telephone-based Care for OEF/OIF Veterans With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Telephone-based Care for OEF/OIF Veterans With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680524).
- Telephone-linked Home-based Exercise Training in PD: Complete Statistical AnalysisIndependent statistical analysis of Telephone-linked Home-based Exercise Training in PD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898740).
- Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00676182).
- Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Telmisartan Pilot Study on Treatment Resistant Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Telmisartan Pilot Study on Treatment Resistant Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03868839).
- Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553267).
- telosIndependent statistical analysis of Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD:…
- Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2): Complete Statistical AnalysisIndependent statistical analysis of Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00723827).
- Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…